Hypotension in a Geriatric Dog with Mitral Valve Disease
A 12-year-old castrated male Yorkshire Terrier (5.2 kg) with a 6-month history of degenerative mitral valve disease (ACVIM stage C) is anesthetized for dental extraction. Current medications: enalapril 2.5 mg PO q12h, furosemide 1 mg/kg PO q12h, pimobendan 0.25 mg/kg PO q12h. Preoperative exam: HR 120 bpm, RR 28, rectal temperature 38.2°C, mucous membranes pink, CRT 1.5 s. Thoracic auscultation reveals a grade 4/6 left apical systolic murmur; no crackles. Echocardiogram 2 weeks ago: left atrial/aortic ratio 1.9, normalized left ventricular internal diameter in diastole 1.85, fractional shortening 42%. Bloodwork: BUN 28 mg/dL, creatinine 1.1 mg/dL, PCV 48%, total protein 7.0 g/dL, sodium 148 mEq/L, potassium 4.2 mEq/L. Anesthesia plan: acepromazine 0.02 mg/kg IM, hydromorphone 0.05 mg/kg IM, propofol to effect, intubation, isoflurane in oxygen, intermittent positive pressure ventilation to maintain normocapnia. During surgery, 20 minutes after induction, HR is 88 bpm, arterial blood pressure (oscillometric) is 78/45 mm Hg (MAP 56 mm Hg), end-tidal isoflurane 1.3%, end-tidal CO2 38 mm Hg, SpO2 98%. The surgeon reports ongoing dental extraction with mild hemorrhage.
1. Interpret the cause(s) of the hypotension and outline your immediate management priorities, including drug choices and targets.
Read the worked answer
The MAP of 56 mm Hg is below the acceptable target (≥60–65 mm Hg) and represents hypotension. Contributing factors: (1) isoflurane-induced vasodilation and myocardial depression at 1.3% end-tidal; (2) acepromazine-induced alpha-1 blockade (though low dose, additive); (3) surgical hemorrhage (mild) reducing preload; (4) bradycardia (HR 88) limiting cardiac output; (5) positive pressure ventilation reducing venous return. In a dog with mitral valve disease, avoid excessive fluid loading that could worsen pulmonary edema, and avoid drugs that increase afterload excessively or cause tachycardia. Immediate steps: reduce isoflurane to 0.8–1.0% end-tidal while monitoring anesthetic depth; ensure adequate analgesia (hydromorphone already given; consider adding a constant rate infusion of fentanyl 5–10 µg/kg/h or ketamine 10–20 µg/kg/min if pain is suspected); assess volume status-if preload is low, give a small crystalloid bolus (5–10 mL/kg over 15–20 min) or colloid (3–5 mL/kg) and reassess; if MAP remains <60 mm Hg, start a vasopressor (norepinephrine 0.05–0.1 µg/kg/min or dopamine 5–10 µg/kg/min) titrated to effect; if bradycardia is contributing, consider anticholinergic (glycopyrrolate 5–10 µg/kg IV) but only if HR is inappropriately low for the blood pressure. Target MAP ≥65 mm Hg, HR 80–120 bpm, normocapnia, and adequate analgesia. Monitor for pulmonary edema (respiratory rate, effort, crackles) postoperatively.
2. What specific concerns does the dog's cardiac disease raise for the anesthetic protocol, and how would you modify the plan preoperatively and intraoperatively?
Read the worked answer
The dog has stage C mitral valve disease with moderate left atrial enlargement (LA/Ao 1.9) and preserved systolic function (FS 42%). Concerns: (1) Increased risk of pulmonary edema if fluid overload occurs; (2) reduced cardiac reserve and ability to compensate for vasodilation; (3) potential for arrhythmias (e.g., atrial fibrillation) due to atrial enlargement; (4) drug interactions-acepromazine may cause hypotension; enalapril and furosemide may potentiate hypotension and prerenal azotemia. Preoperative modifications: continue cardiac medications (especially pimobendan and enalapril) up to the morning of surgery unless instructed otherwise; avoid prolonged fasting; consider thoracic radiographs to assess for pulmonary edema; ensure adequate hydration but avoid overhydration; preoxygenate. Intraoperative modifications: avoid acepromazine if possible-use an opioid alone (e.g., methadone 0.2 mg/kg IM) plus a benzodiazepine (midazolam 0.2 mg/kg IM) for premedication; induce with etomidate (0.5–1 mg/kg IV) or a benzodiazepine-ketamine combination to minimize cardiovascular depression; maintain with isoflurane or sevoflurane at the lowest effective concentration, supplemented with an opioid infusion (fentanyl or remifentanil) and possibly a lidocaine infusion (loading dose 2 mg/kg IV, then 50 µg/kg/min) for analgesia and to reduce volatile requirement; use mechanical ventilation to maintain normocapnia; monitor blood pressure invasively if possible; have vasopressors and anticholinergics ready; restrict fluid rates to 3–5 mL/kg/h and use small boluses if needed. Postoperative: monitor respiratory rate and effort closely for 24–48 hours; continue pimobendan and furosemide as prescribed; provide multimodal analgesia.